Joe Fenn
Pulmonary Disease · Williamsburg, VANPI 1184617466
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AstraZeneca at 25.4% of the total. Reporting peaked in 2019 at $1,523 and has fallen 92.7% since, to $112 in 2022. That places this record below the midpoint for pulmonary disease clinicians in VA, where the typical reported total is $1,962.
Across 72 payments — averaging $23.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$431
- GSK$214
- Philips North America LLC$151
- Genentech USA, Inc.$147
- Inspire Medical Systems, Inc.$136
- Mallinckrodt Hospital Products Inc.$112
- plus $508 from 16 others
What the payments were for
- Food & beverage$1,699100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 13 | $431 |
| GSK | 16 | $214 |
| Philips North America LLC | 8 | $151 |
| Genentech USA, Inc. | 7 | $147 |
| Inspire Medical Systems, Inc. | 1 | $136 |
| Mallinckrodt Hospital Products Inc. | 1 | $112 |
| Advanced Respiratory, Inc | 2 | $80 |
| Boehringer Ingelheim | 4 | $76 |
| Mallinckrodt Enterprises LLC | 3 | $55 |
| Bristol Myers Squibb | 2 | $40 |
| Sunovion Pharmaceuticals Inc. | 2 | $39 |
| Gilead | 2 | $32 |
| Actelion Pharmaceuticals US, Inc. | 1 | $28 |
| Jazz Pharmaceuticals Inc. | 2 | $24 |
| Grifols USA, LLC | 1 | $23 |
| Novartis | 1 | $19 |
| Resmed Corp | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Amgen | 1 | $16 |
| Shire North American Group Inc | 1 | $15 |
| Mylan Specialty L.p. | 1 | $13 |
| Circassia Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,699 in reported general payments places this provider in the 45th percentile of 317 pulmonary disease providers in Virginia.
Other pulmonary disease in Williamsburg
- Vijay SubramaniamWilliamsburg$228K
- Steven NathanFalls Church$1.5M
- Omar MinaiHopewell$1.3M
- Rabih HalabiFalls Church$604K
- Eric LibreAnnandale$302K
- Sujoy GillRichmond$296K
- Imre NothCharlottesville$256K
- Carlos SilvaChesapeake$245K
- Ellen VolkerCharlottesville$177K
- Himanshu DesaiChesapeake$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.